- Report
- December 2023
- 96 Pages
Middle East, Africa
From €3131EUR$3,450USD£2,640GBP
- Report
- December 2023
- 113 Pages
Europe
From €3131EUR$3,450USD£2,640GBP
- Report
- December 2023
- 106 Pages
Asia Pacific
From €3131EUR$3,450USD£2,640GBP
- Report
- September 2023
- 196 Pages
Global
From €4039EUR$4,450USD£3,405GBP
From €4039EUR$4,450USD£3,405GBP
- Report
- April 2021
- 148 Pages
Europe
From €3131EUR$3,450USD£2,640GBP
- Report
- April 2021
- 150 Pages
Asia Pacific
From €3131EUR$3,450USD£2,640GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4492EUR$4,950USD£3,787GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4492EUR$4,950USD£3,787GBP
- Report
- January 2022
- 60 Pages
Global
From €3585EUR$3,950USD£3,022GBP
- Report
- May 2024
- 160 Pages
Global
From €2269EUR$2,500USD£1,913GBP
- Report
- May 2024
- 170 Pages
Global
From €2269EUR$2,500USD£1,913GBP
- Report
- March 2022
- 120 Pages
Global
From €2269EUR$2,500USD£1,913GBP
- Report
- March 2022
- 120 Pages
Global
From €2269EUR$2,500USD£1,913GBP
- Report
- June 2024
- 200 Pages
Global
From €7215EUR$7,950USD£6,082GBP
- Report
- June 2024
- 200 Pages
Global
From €7215EUR$7,950USD£6,082GBP
- Report
- June 2024
- 200 Pages
Global
From €7215EUR$7,950USD£6,082GBP
- Report
- June 2024
- 200 Pages
Global
From €7215EUR$7,950USD£6,082GBP
- Report
- June 2024
- 200 Pages
Global
From €7215EUR$7,950USD£6,082GBP
- Report
- June 2024
- 200 Pages
Global
From €7215EUR$7,950USD£6,082GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more